Shalekoff Sharon, Meddows-Taylor Stephen, Gray Glenda E, Sherman Gayle G, Coovadia Ashraf H, Kuhn Louise, Tiemessen Caroline T
AIDS Virus Research Unit, National Institute for Communicable Diseases, Sandringham 2131, South Africa.
AIDS. 2009 Apr 27;23(7):789-98. doi: 10.1097/QAD.0b013e328329c784.
There are few data describing the specificity, breadth and magnitude of T cell responses to HIV-1 in infancy.
HIV-specific CD8+ and CD4+ T cell responses to peptide pools representing Gag, Env, Pol, Nef and the regulatory regions (Reg) were simultaneously measured in 18 perinatally-infected infants and 14 of their chronically-infected mothers, using a whole blood interleukin-2 and interferon-gamma flow cytometric intracellular cytokine staining assay.
HIV-specific CD8+ T cell responses were detected in all the infants aged 6 weeks and older (range 0.1-6.62%) and their mothers (range 0.1-4.89%). HIV-specific CD4+ T cell responses were detected in 33% of the infants (range 0.11-0.54%) and 73% of the mothers (range 0.16-0.84). CD8+ T cell responses in the mothers were almost equally spread between the variable (Nef, Reg and Env) and conserved proteins (Gag and Pol). Conversely, CD8+ T cell responses to the more variable proteins dominated in the perinatally-infected infants comprising 74% of the total response. Interestingly, mothers and infants shared responses to at least one peptide pool, whereas only one mother-infant pair shared a peptide pool targeted by CD4+ T cells. Two in-utero-infected infants tested at birth had CD8+ T cell responses, and one of them had an Env-specific CD4 T cell response.
Our observations that HIV-specific CD8+ and CD4+ T cell responses can be detected in perinatally-infected infants from 6 weeks of age and that CD8+ T cell responses predominantly target the variable proteins have important implications for HIV vaccine design.
关于婴儿期T细胞对HIV-1反应的特异性、广度和强度的数据很少。
采用全血白细胞介素-2和干扰素-γ流式细胞术细胞内细胞因子染色测定法,同时检测了18名围产期感染婴儿及其14名慢性感染母亲对代表Gag、Env、Pol、Nef和调节区(Reg)的肽池的HIV特异性CD8+和CD4+T细胞反应。
在所有6周及以上的婴儿(范围为0.1-6.62%)及其母亲(范围为0.1-4.89%)中均检测到HIV特异性CD8+T细胞反应。在33%的婴儿(范围为0.11-0.54%)和73%的母亲(范围为0.16-0.84%)中检测到HIV特异性CD4+T细胞反应。母亲的CD8+T细胞反应在可变蛋白(Nef、Reg和Env)和保守蛋白(Gag和Pol)之间分布几乎相等。相反,在围产期感染的婴儿中,对更多可变蛋白的CD8+T细胞反应占主导,占总反应的74%。有趣的是,母亲和婴儿至少对一个肽池有共同反应,而只有一对母婴对共享一个CD4+T细胞靶向的肽池。两名出生时检测的宫内感染婴儿有CD8+T细胞反应,其中一名有Env特异性CD4 T细胞反应。
我们观察到,在6周龄的围产期感染婴儿中可以检测到HIV特异性CD8+和CD4+T细胞反应,并且CD8+T细胞反应主要针对可变蛋白,这对HIV疫苗设计具有重要意义。